HCA Health Inc vs KKR & Co Inc — how do they compare? HCA Health Inc trades at $450.18 (market cap $96.35B), while KKR & Co Inc trades at $90.95 (market cap $80.39B). The key difference: HCA Health Inc is the larger of the two by market cap, and KKR & Co Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and KKR & Co Inc for 67 Days on average.
| HCA | KKR | |
|---|---|---|
Market Cap | $96.35B | $80.39B |
Volume | 1,079,453 | 6,517,705 |
Sector | Health | Financials |
52-Week High | $545.13 | $142.75 |
52-Week Low | $361.32 | $83.88 |
Typical Hold Time | 76 Days | 67 Days |
Enterprise Value | $146.88B | $2.95B |
Dividend Yield | 0.7% | 0.87% |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $451.09, up 2.71% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q4 2025 and Q1-Q2 2026 exceeding expectations, supported by robust revenue growth from $70.6B in 2024 to $75.6B in 2025. Valuation metrics remain attractive with P/E of 14.92 and P/S of 1.31, while technical indicators signal bullish momentum above key support levels.
The outlook remains positive with 63% analyst buy ratings and $461.12 consensus target, though legal investigations and high debt levels pose risks. Revenue growth and operational efficiency provide upside potential, but investors should monitor regulatory developments and debt management closely given the 80.9% debt-to-asset ratio in 2025.
KKR trades at $90.95, up 1.43% on the day, with strong analyst support showing 24 buy ratings and a $123.30 consensus price target. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Technical indicators are bearish overall, with RSI levels suggesting potential oversold conditions. The company maintains solid profitability with 14.97% net income margin and continues active portfolio management through recent acquisitions and divestitures.
The investment case for KKR appears favorable given the significant upside to analyst targets and strong institutional support. However, investors face risks from volatile cash flows, high debt levels, and market-sensitive revenue streams. The upcoming Q3 2026 earnings report on November 9 will be crucial for validating current valuation metrics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →